This content is restricted.
Brief
The Drug Alert for November 2024, issued by CDSCO, identifies multiple Not of Standard Quality (NSQ) drugs, citing failures in sterility, assay, dissolution, particulate matter, and labeling violations. The report serves as a critical warning to healthcare professionals, pharmaceutical companies, and consumers, urging immediate action to remove non-compliant batches from circulation and reinforce quality control measures in drug manufacturing.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested